Is the prevalence of colonic neuroendocrine tumors increased in patients with inflammatory bowel disease?

Abstract

Inflammatory bowel disease (IBD) patients may bear an increased neuroendocrine tumor (NET) risk. These tumors are mostly reported as coincidental findings during surgery. We aimed to determine the prevalence of colonic NET in a Dutch nationwide IBD cohort and calculate the prevalence rate ratios (PRR) compared to the general Dutch population. Our second aim was to investigate whether a high bowel surgery rate in IBD could result in a high PRR for NET.

The Dutch Pathology Registry (PALGA) was searched to identify all IBD patients with colonic NET in The Netherlands between 1991 and 2011. We determined the prevalence and PRR of colonic NET in a 20-year period. For our second aim, we compared NET prevalence in colonic resection specimens between IBD cases and non-IBD controls (diverticulitis and ischemia).

We identified 51 IBD patients who developed colonic NET resulting in a prevalence of 60.4 - 89.3 per 100 000 patients in a 20-year period with a PRR of 2.8 - 4.1. However, adjusted for resection type, sex and age, a higher NET prevalence was shown in diverticulitis (OR 5.52, 95% CI 3.47 - 8.78) and ischemia (OR 1.97, 95% CI 1.09 - 3.58) compared to IBD.

Our key finding is that NET are more prevalent in IBD patients compared to the general population (PRR 2.8 - 4.1). This might be attributed to a high rate of incidental NET as IBD patients frequently undergo intestinal surgery. A lower adjusted NET prevalence in colonic resection specimens for IBD compared to ischemia and diverticulitis supports this hypothesis. This article is protected by copyright. All rights reserved.

from Cancer via ola Kala on Inoreader http://ift.tt/1XyW59l
via IFTTT